Recursion issues 7.1M shares to Tempus AI for license fees; registers for resale

RECURSION PHARMACEUTICALS, INC.

Issued 7,088,742 Class A shares to Tempus AI on Nov 24, 2025 as payment for annual license fees.
Shares registered for resale via prospectus supplement filed Nov 26, 2025 under existing shelf registration.
Issuance stems from Master Agreement dated Nov 9, 2023, as previously disclosed in an 8-K.
Resale registration may allow Tempus to sell shares, creating potential dilution for existing holders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.